Booster Vaccination against SARS-CoV-2 Induces Potent Immune Responses in People with HIV

Adults with HIV were enrolled into a single arm open label study. Two doses of ChAdOx1 nCoV-19 were followed twelve months later by a third heterologous vaccine dose.